TY - JOUR
T1 - A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk
AU - Bouatia-Naji, Nabila
AU - Bonnefond, Amélie
AU - Cavalcanti-Proença, Christine
AU - Sparsø, Thomas
AU - Holmkvist, Johan
AU - Marchand, Marion
AU - Delplanque, Jérôme
AU - Lobbens, Stéphane
AU - Rocheleau, Ghislain
AU - Durand, Emmanuelle
AU - De Graeve, Franck
AU - Chèvre, Jean-Claude
AU - Borch-Johnsen, Knut
AU - Hartikainen, Anna-Liisa
AU - Ruokonen, Aimo
AU - Tichet, Jean
AU - Marre, Michel
AU - Weill, Jacques
AU - Heude, Barbara
AU - Tauber, Maithé
AU - Lemaire, Katleen
AU - Schuit, Frans
AU - Elliott, Paul
AU - Jørgensen, Torben
AU - Charpentier, Guillaume
AU - Hadjadj, Samy
AU - Cauchi, Stéphane
AU - Vaxillaire, Martine
AU - Sladek, Robert
AU - Visvikis-Siest, Sophie
AU - Balkau, Beverley
AU - Lévy-Marchal, Claire
AU - Pattou, François
AU - Meyre, David
AU - Blakemore, Alexandra I F
AU - Jarvelin, Marjo-Riita
AU - Walley, Andrew J
AU - Hansen, Torben
AU - Dina, Christian
AU - Pedersen, Oluf
AU - Froguel, Philippe
N1 - Keywords: Adaptor Proteins, Signal Transducing; Adolescent; Adult; Blood Glucose; Child; Chromosomes, Human, Pair 11; Cohort Studies; Diabetes Mellitus, Type 2; Fasting; Gene Expression Profiling; Gene Expression Regulation; Genetic Predisposition to Disease; Genome-Wide Association Study; Glucokinase; Humans; Insulin Resistance; Islets of Langerhans; Meta-Analysis as Topic; Middle Aged; Polymorphism, Single Nucleotide; RNA, Messenger; Receptor, Melatonin, MT2; Receptors, Melatonin; Reproducibility of Results
PY - 2009
Y1 - 2009
N2 - In genome-wide association (GWA) data from 2,151 nondiabetic French subjects, we identified rs1387153, near MTNR1B (which encodes the melatonin receptor 2 (MT2)), as a modulator of fasting plasma glucose (FPG; P = 1.3 x 10(-7)). In European populations, the rs1387153 T allele is associated with increased FPG (beta = 0.06 mmol/l, P = 7.6 x 10(-29), N = 16,094), type 2 diabetes (T2D) risk (odds ratio (OR) = 1.15, 95% CI = 1.08-1.22, P = 6.3 x 10(-5), cases N = 6,332) and risk of developing hyperglycemia or diabetes over a 9-year period (hazard ratio (HR) = 1.20, 95% CI = 1.06-1.36, P = 0.005, incident cases N = 515). RT-PCR analyses confirm the presence of MT2 transcripts in neural tissues and show MT2 expression in human pancreatic islets and beta cells. Our data suggest a possible link between circadian rhythm regulation and glucose homeostasis through the melatonin signaling pathway.
AB - In genome-wide association (GWA) data from 2,151 nondiabetic French subjects, we identified rs1387153, near MTNR1B (which encodes the melatonin receptor 2 (MT2)), as a modulator of fasting plasma glucose (FPG; P = 1.3 x 10(-7)). In European populations, the rs1387153 T allele is associated with increased FPG (beta = 0.06 mmol/l, P = 7.6 x 10(-29), N = 16,094), type 2 diabetes (T2D) risk (odds ratio (OR) = 1.15, 95% CI = 1.08-1.22, P = 6.3 x 10(-5), cases N = 6,332) and risk of developing hyperglycemia or diabetes over a 9-year period (hazard ratio (HR) = 1.20, 95% CI = 1.06-1.36, P = 0.005, incident cases N = 515). RT-PCR analyses confirm the presence of MT2 transcripts in neural tissues and show MT2 expression in human pancreatic islets and beta cells. Our data suggest a possible link between circadian rhythm regulation and glucose homeostasis through the melatonin signaling pathway.
U2 - 10.1038/ng.277
DO - 10.1038/ng.277
M3 - Journal article
C2 - 19060909
SN - 1061-4036
VL - 41
SP - 89
EP - 94
JO - Nature: New biology
JF - Nature: New biology
IS - 1
ER -